Stay updated on PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Sign up to get notified when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Cosmetic UI adjustments observed (overlay elements and layout tweaks). Core study content such as eligibility criteria, interventions, and primary outcomes remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:37.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.0' was added and the previous label 'Revision: v3.4.3' was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:37.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 (v3.4.2 removed) on the page footer.
    Difference
    0.1%
    Check dated 2026-03-12T00:27:41.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing Revision: v3.4.1, and a government funding status notice was removed with no changes to the trial details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:58:13.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Site-wide notices about funding status and a revision update (Revision: v3.4.1, replacing v3.4.0) were added; these do not modify study data, eligibility criteria, or other core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:26:35.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a glossary display option, a new QC-related label (Last Update Submitted that Met QC Criteria), and a new revision tag (Revision: v3.4.0). Removed the previous QC label variant (Last Update Submitted that met QC Criteria), removed the No FEAR Act data label as a separate item, and adjusted capitalization for No FEAR Act Data and the older revision tag (Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T06:00:47.000Z thumbnail image

Stay in the know with updates to PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.